HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Plaintiffs Branching From Natural To Clean-Type Claims, Attorneys Warn At PCPC Virtual Summit

Executive Summary

Are botanical claims equivalent to natural claims? Can hair truly be repaired? What constitutes “oil-free”? Such are the questions raised in growing litigation against cosmetic product companies under consumer protection statutes around the US, Conkle, Kremer & Engel attorneys say.

You may also be interested in...



Unilever To Fuel Skin Care, E-Commerce Engines With Paula’s Choice Acquisition

Paula’s Choice ticks skin-care and e-commerce boxes at a time of increased wellness and home shopping demand. The balance it strikes between acknowledging consumer ingredient preferences and upholding scientific method may also be part of the brand's appeal.

California Federal Court Rejects Settlement Proposal In Coppertone ‘Mineral-Based’ Sunscreen Case

Beiersdorf and former owner Bayer are on the verge of settling a proposed class action in California’s Northern District challenging “mineral-based” claims on Coppertone sunscreens that also contain chemical UV filters. However, the parties will have to try again with their proposed terms.

J&J’s OGX Joins Brands Alleged To Cause Hair Loss In US Class Action Complaints

Formaldehyde donor DMDM hydantoin may be the ingredient in OGX hair-care products responsible for “hundreds if not thousands” of cases of hair loss and other injuries, plaintiff La Wanda Renee Key suggests in her 5 March class action complaint in California federal court.

Related Content

Topics

UsernamePublicRestriction

Register

RS151322

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel